Complete Genomics Warns of Potentially Dire Circumstances if BGI Buy Falls Through | GenomeWeb

NEW YORK (GenomeWeb News) – As Complete Genomics waits on completion of its proposed purchase by BGI-Shenzhen, it said in its Form 10-Q that if the deal were to fall through there is "substantial doubt" about its ability to continue as a going concern.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.